Personal Genomics, PacBio Settle 2019 Suit on Sequencing Patent

May 1, 2026, 3:30 PM UTC

Personal Genomics Taiwan Inc. and Pacific Biosciences of California Inc. settled a case Personal Genomics launched more than six years ago alleging PacBio’s Sequel system infringes a genetic sequencing patent.

Menlo Park, Calif.-based PacBio and the Personal Genomics Inc. subsidiary agreed to dismiss the lawsuit with prejudice, including all claims, counterclaims, and defenses, according to a stipulation of dismissal filed Thursday in the US District Court for the Northern District of California.

The parties said in a March 13 notice that they’d “agreed to a binding settlement” and asked the court to clear from its calendar all pending dates scheduled ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.